FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series B / Biotech startups that raised Series B in Europe

Biotech startups that raised Series B in Europe

Updated 16 Nov 2026

Reset
Biotech startups that raised Series B in Europe
One-time CSV
  • 249 funded companies, 164 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-b~europe.csv249 rows × 18 columns
CompanyCityLast roundAmountDate
T-TherapeuticsCambridgeSeries B$133.0M2026-11-05
Onego BioHelsinkiSeries B$28.0M2026-10-26
Sava TechnologyLondonSeries B$36.0M2026-10-09
WhiteLab GenomicsParisSeries B$26.0M2026-10-05
NovaGo TherapeuticsSchlierenSeries B$29.7M2026-08-31
Pixelgen TechnologiesStockholmSeries B$15.5M2026-08-20
ComputomicsTübingenSeries B$7.3M2026-08-18
Vaderis TherapeuticsBaselSeries B$152.0M2026-08-11

8 rows of the CSV in 5 of its 18 columns.

249
Startups
$7.5B
Total raised
22
Funded in the last 12 months
$1.2B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 249
30 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge, United Kingdom Series B $133.0M 2026-11-05 $224.6M F-Prime, Sofinnova Partners, Digitalis Ventures +2 51 to 100 2022
Onego Bio Onego Bio produces egg protein through fermentation as a food ingredient. Biotech Helsinki, Finland Series B $28.0M 2026-10-26 $100.6M European Innovation Council, Business Finland, Tesi +2 11 to 50 2022
Sava Technology Sava Technology creates under-skin sensors that continuously monitor glucose, lactate, and ketones. Biotech London, United Kingdom Series B $36.0M 2026-10-09 $62.8M SOSV, Balderton Capital, Social Starts +1 101 to 250 2016
WhiteLab Genomics WhiteLab Genomics builds digital tools that help gene and cell therapy companies develop drugs faster and cheaper. Artificial intelligence Paris, France Series B $26.0M 2026-10-05 $36.5M Y Combinator, Omnes Capital 11 to 50 2019
NovaGo Therapeutics NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. Biotech Schlieren, Switzerland Series B $29.7M 2026-08-31 $39.7M Kinled Holding, Pureos Bioventures 1 to 10 2015
Pixelgen Technologies Pixelgen Technologies develops technologies for biomedical research and diagnostics. Biotech Stockholm, Sweden Series B $15.5M 2026-08-20 $43.5M Industrifonden, Navigare Ventures, Colibri Ventures +1 11 to 50 2020
Computomics Computomics applies artificial intelligence to genomics data to advance agricultural solutions. Artificial intelligence Tübingen, Germany Series B $7.3M 2026-08-18 $10.0M HTGF (High-Tech Gruenderfonds), VentureOut, European Innovation Council +2 11 to 50 2012
Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Basel, Switzerland Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019
Mironid Mironid discovers drugs to treat degenerative kidney diseases, chronic inflammatory diseases, and cancer. Biotech Glasgow, United Kingdom Series B $45.9M 2026-08-05 $90.6M Scottish Enterprise, Sofinnova Partners, European Investment Fund +1 11 to 50 2014
NVision Quantum Technologies NVision Quantum Technologies develops quantum-based imaging technology that enhances standard MRI systems. Biotech Ulm, Germany Series B $38.0M 2026-05-13 $155.2M Entrée Capital, European Commission, Playground Global +2 101 to 250 2015
Windward Bio Windward Bio develops monoclonal antibodies for advanced immunological diseases. Biotech Basel, Switzerland Series B $165.0M 2026-05-04 $365.0M Qiming Venture Partners, OrbiMed, Novo Holdings +2 11 to 50 2024
Standing Ovation Standing Ovation produces animal-free dairy proteins using precision fermentation food technology. Biotech Paris, France Series B $28.6M 2026-03-31 $53.8M Bpifrance, Seventure Partners, Big Idea Ventures +2 11 to 50 2021
Orbem Orbem provides AI-powered imaging and analytics for non-invasive biological insights. Artificial intelligence Munich, Germany Series B $64.6M 2026-01-20 $106.5M European Innovation Council, Possible Ventures, 83North +1 101 to 250 2019
Exciva Exciva develops clinical-stage biopharmaceutical therapies for neuropsychiatric symptoms of dementia. Biotech Heidelberg, Germany Series B $59.4M 2026-01-20 $69.8M Andera Partners, LBBW VC, Cure8 Ventures 1 to 10 2015
Lattice Medical Lattice Medical makes 3D printed bioabsorbable medical devices for breast reconstruction. Biotech Loos, France Series B $50.0M 2025-10-24 $63.3M Bpifrance, European Innovation Council, MedTech Innovator +1 11 to 50 2017
OXCCU OXCCU converts carbon dioxide and hydrogen into synthetic fuels, chemicals, and biodegradable plastics. Biotech Oxford, United Kingdom Series B $27.9M 2025-09-29 $54.1M IP Group, Aramco Ventures, Clean Energy Ventures +1 1 to 10 2021
Cyted Cyted uses AI and digital pathology to improve the detection and diagnosis of diseases, including cancer. Artificial intelligence Cambridge, United Kingdom Series B $44.0M 2025-08-30 $83.4M Innovate UK, MedTech Innovator, Morningside +1 51 to 100 2018
SNIPR Biome SNIPR Biome develops discovery-stage biotech treatments for microbial diseases. Biotech Copenhagen, Denmark Series B $40.9M 2025-08-07 $103.4M Wellington Partners, Bill & Melinda Gates Foundation, EQT Life Sciences +1 11 to 50 2017
GlycoEra GlycoEra researches and produces extracellular protein degraders for treating autoimmune diseases. Biotech Wädenswil, Switzerland Series B $130.0M 2025-05-27 $179.3M Sofinnova Partners, Bristol-Myers Squibb, 5AM Ventures +1 11 to 50 2020
TILT Biotherapeutics TILT Biotherapeutics develops therapies that enable the immune system to attack tumors. Biotech Helsinki, Finland Series B $25.3M 2025-05-13 $71.1M European Innovation Council, Business Finland, Lifeline Ventures +1 11 to 50 2013
Seqera Seqera provides tools that make complex data analysis scalable for genomics and global health research. Biotech Barcelona, Spain Series B $26.0M 2025-05-06 $53.0M Creative Destruction Lab, Speedinvest, Talis Capital +1 101 to 250 2018
Clinomic Clinomic is a medical AI company focused on critical care. Artificial intelligence Aachen, Germany Series B $25.3M 2025-04-08 $54.6M German Federal Ministry of Research, Technology and Space 51 to 100 2019
NETRI NETRI develops technologies for the pharmaceutical industry. Biotech Lyon, France Series B $5.1M 2025-02-02 $5.1M Next Innov Prize 11 to 50 2018
Noema Pharma Noema Pharma develops therapies that treat disabling symptoms of brain and nervous system conditions. Biotech Basel, Switzerland Series B $147.2M 2024-12-11 $316.5M Polaris Partners, Sofinnova Partners, Invus +2 11 to 50 2019
Cradle Cradle uses AI prediction algorithms to help biologists design proteins. Artificial intelligence Delft, The Netherlands Series B $73.0M 2024-11-26 Index Ventures, IVP, Kindred Capital 11 to 50 2021
SynOx Therapeutics SynOx Therapeutics is a biotechnology company developing treatments for diffuse tenosynovial giant cell tumors. Biotech Dublin, Ireland Series B $92.0M 2024-10-30 $245.9M Forbion Capital Partners, Gimv, Hercules Capital +2 1 to 10 2020
Qualifyze Qualifyze provides global quality audit and site risk management solutions for life sciences companies. Biotech Frankfurt, Germany Series B $54.0M 2024-09-10 Insight Partners, APX, HV Capital +2 101 to 250 2019
CorFlow Therapeutics CorFlow Therapeutics develops proprietary technologies to diagnose and treat microvascular obstructions. Biotech Baar, Switzerland Series B $48.5M 2024-09-10 $66.1M Innosuisse, Unorthodox Ventures, Panakes Partners +2 11 to 50 2016
Vico Therapeutics Vico Therapeutics develops RNA modulating therapies. Biotech Leiden, The Netherlands Series B $12.3M 2024-06-24 $115.4M Polaris Partners, Eurazeo, EQT Life Sciences +2 11 to 50 2019
iOnctura iOnctura is a clinical-stage biotechnology company developing treatments for cancer. Biotech Geneva, Switzerland Series B $85.7M 2024-06-20 European Innovation Council, M Ventures, VI Partners +2 11 to 50 2017

Table 1. Biotech startups that raised Series B in Europe: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 249.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 Windward Bio Windward Bio develops monoclonal antibodies for advanced immunological diseases. Biotech Basel, Switzerland Series B $165.0M 2026-05-04 $365.0M Qiming Venture Partners, OrbiMed, Novo Holdings +2 11 to 50 2024
2 Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Basel, Switzerland Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019
3 T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge, United Kingdom Series B $133.0M 2026-11-05 $224.6M F-Prime, Sofinnova Partners, Digitalis Ventures +2 51 to 100 2022
4 Orbem Orbem provides AI-powered imaging and analytics for non-invasive biological insights. Artificial intelligence Munich, Germany Series B $64.6M 2026-01-20 $106.5M European Innovation Council, Possible Ventures, 83North +1 101 to 250 2019
5 Exciva Exciva develops clinical-stage biopharmaceutical therapies for neuropsychiatric symptoms of dementia. Biotech Heidelberg, Germany Series B $59.4M 2026-01-20 $69.8M Andera Partners, LBBW VC, Cure8 Ventures 1 to 10 2015
6 Mironid Mironid discovers drugs to treat degenerative kidney diseases, chronic inflammatory diseases, and cancer. Biotech Glasgow, United Kingdom Series B $45.9M 2026-08-05 $90.6M Scottish Enterprise, Sofinnova Partners, European Investment Fund +1 11 to 50 2014
7 NVision Quantum Technologies NVision Quantum Technologies develops quantum-based imaging technology that enhances standard MRI systems. Biotech Ulm, Germany Series B $38.0M 2026-05-13 $155.2M Entrée Capital, European Commission, Playground Global +2 101 to 250 2015
8 Sava Technology Sava Technology creates under-skin sensors that continuously monitor glucose, lactate, and ketones. Biotech London, United Kingdom Series B $36.0M 2026-10-09 $62.8M SOSV, Balderton Capital, Social Starts +1 101 to 250 2016
9 NovaGo Therapeutics NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. Biotech Schlieren, Switzerland Series B $29.7M 2026-08-31 $39.7M Kinled Holding, Pureos Bioventures 1 to 10 2015
10 Standing Ovation Standing Ovation produces animal-free dairy proteins using precision fermentation food technology. Biotech Paris, France Series B $28.6M 2026-03-31 $53.8M Bpifrance, Seventure Partners, Big Idea Ventures +2 11 to 50 2021

Table 2. Biotech startups that raised Series B in Europe: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 HTGF (High-Tech Gruenderfonds) Venture capital firm Bonn, Germany 16 6% 1 Computomics
2 European Innovation Council Startup accelerator Brussels, Belgium 8 3% 3 Onego Bio, Computomics, Orbem
3 Sofinnova Partners Venture capital firm Paris, France 6 2% 2 T-Therapeutics, Mironid
4 Bpifrance Government investment office Maisons-alfort, France 6 2% 1 Standing Ovation
5 Andera Partners Private equity firm Paris, France 6 2% 1 Exciva
6 EQT Life Sciences Private equity firm Amsterdam, The Netherlands 6 2%
7 Forbion Capital Partners Private equity firm Naarden, The Netherlands 5 2%
8 Innovate UK Entrepreneurship program Swindon, United Kingdom 4 2%
9 Bristol-Myers Squibb Venture capital firm New York, United States 4 2%
10 Index Ventures Venture capital firm San Francisco, United States 4 2%
11 Venture Kick Startup incubator Schlieren, Switzerland 4 2%
12 VI Partners Venture capital firm Altendorf, Switzerland 4 2%
13 KfW Government investment office Frankfurt, Germany 4 2%
14 NRW.BANK Government investment office Düsseldorf, Germany 4 2%
15 Boehringer Ingelheim Venture Fund Corporate venture arm Ingelheim Am Rhein, Germany 4 2%

Table 3. Biotech startups that raised Series B in Europe: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 197 79% $6.6B
Software 22 9% $641.5M
Artificial intelligence 11 4% $384.0M
Hardware 5 2% $195.9M
Cybersecurity 2 1% $25.7M
Education 2 1% $284.5M
Fintech 2 1%
Energy 1 0% $54.1M
Commerce 1 0%

Table 4. Biotech startups that raised Series B in Europe by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 249 100% $20.0M

Table 5. Biotech startups that raised Series B in Europe by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
United Kingdom 72 29%
France 38 15%
Germany 35 14%
Switzerland 31 12%
The Netherlands 14 6%
Belgium 13 5%
Spain 10 4%
Ireland 10 4%
Italy 8 3%
Denmark 7 3%
Finland 5 2%
Sweden 4 2%

Table 6. Biotech startups that raised Series B in Europe by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
London 23 9%
Cambridge 15 6%
Paris 14 6%
Oxford 9 4%
Basel 7 3%
Dublin 7 3%
Munich 5 2%
Geneva 5 2%
Madrid 5 2%
Schlieren 4 2%
Barcelona 4 2%
Milan 3 1%

Table 7. Biotech startups that raised Series B in Europe by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 5% $133.0M
October 2026 3 14% $90.0M
September 2026 1 5% $70.8M
August 2026 5 23% $250.4M
July 2026 1 5% $65.0M
June 2026 4 18% $168.6M
May 2026 2 9% $203.0M
March 2026 1 5% $28.6M
January 2026 4 18% $159.2M

Table 8. Biotech startups that raised Series B in Europe: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 22 9% $1.2B
2025 30 12% $1.5B
2024 29 12% $1.4B
2023 14 6% $329.2M
2022 17 7% $624.0M
2021 19 8% $952.9M

Table 9. Biotech startups that raised Series B in Europe by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 2 1%
2020 to 2022 19 8%
2015 to 2019 83 33%
2010 to 2014 56 23%
Before 2010 88 35%

Table 10. Biotech startups that raised Series B in Europe by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 56 23%
11 to 50 135 55%
51 to 100 33 13%
101 to 250 17 7%
251 to 500 1 0%
501 to 1,000 1 0%
1,001 to 5,000 1 0%
10,001 or more 1 0%

Table 11. Biotech startups that raised Series B in Europe by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Europe whose last round is Series B are on the list?
249, in the file dated 16 November 2026. 22 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 249 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series B in Europe: 249 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Europe

Other sectors that raised Series B in Europe

Cite: FundingWatcher, 249 biotech companies in Europe whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-b/europe/